Justine studied biological sciences at the University of Warwick before diving straight into a PhD at the same institution, working on how HIV hijacks certain transport pathways in cells. After subsequently working as a science writer for several years, Justine joined the Science Communications team at Cancer Research UK in 2016, helping communicate research on cancer to the public and media.
Our researchers are working on a new way to improve chemotherapy treatment for aggressive brain tumours, using the precious metal palladium.
Our scientists are working to improve brain tumour diagnosis. Find out how this could make treatment more personal, and guide people onto clinical trials.
Growing ‘mini brains’ in dishes is just one of the innovative ways our scientists are studying brain tumours in the lab. Find out how this could lead to new treatments.
Eradicating diseases isn’t easy. Here we look at which cancers are preventable, and how detecting cancers earlier could make a difference.
Thanks to a trial we supported, people with a type of brain tumour now have a new treatment option – a chemotherapy we developed.
DIPG is a fatal childhood brain tumour. But our scientists are unpicking its biology in the hope of finding new ways to tackle this hard to treat cancer.
Two over-the-counter, widely available drugs could help cut cases of oesophageal cancer in people at higher risk of the disease.
By revealing a tumour’s past, our scientists are opening the possibility of predicting its future. This could help make cancer treatment more personal.
Brain tumour researchers face many challenges that are holding up progress. Find out how we’re bringing scientists together to overcome them.
In this instalment of our Science Surgery series, we explore what gives a cell the potential to become cancerous, and how the body stops this from happening.